Cancer Center

company image

Winship Cancer Institute of Emory University

Winship Cancer Institute of Emory University

The Winship Cancer Institute is the premier cancer institute in the state of Georgia, as it has established itself at the sole facility with distinguishments from the National Cancer Institute. Based out of Atlanta, the center’s rich resources are enhanced by its father organization, Emory University.

Treatment options are diverse and range from medical oncology, thoracic surgery, and pulmonology to bring world class care to patients. The core values of the WCI are aligned with a multidisciplinary approach to the accurate and speedy diagnosis of illness, a personalized treatment plan, and the ongoing research and study of cancer through clinical trials and procedures. These clinical trials have caught the attention of a plethora of renown organizations that support the center with over $27 million in funding. Some of these organizations include the Centers for Disease Control and Prevention, the American Cancer Society, and Georgia State University.

The center’s commitment to excellence and effectiveness in patient care attracts thousands of individuals throughout the Southeast, with over 4,800 new cancer patients annually.

Constantly striving to improve treatment plans and clinical care, the WCI and the Georgia Institute of Technology collaborate to create one of the brightest biomedical research institutes in the nation. This partnership enable the researchers of both parties to cooperate more efficiency by combining their state of the art resources while discussing new cancer treatment strategies to extend the lifespan of patients.

The primary focus of the Winship Cancer Institute is the effective treatment of all forms of cancer. The most important aspect in its treatment is a diverse, exceptional team of medical professional with proven experience and a deep commitment to the collaborative efforts involved in its treatment.

Mesothelioma is treated vigorously by the team of thoracic surgeons, radiologists, and oncologists.

One of the world’s most esteemed lung cancer experts is Dr. Daniel Miller. His specialties in dysphagia, lobectomy, and thoracic surgery make him the ideal surgical director of the Thoracic Oncology Program at the institute. Mesothelioma treatment is of utmost importance in his medical work, often using a combination of traditional treatment options with more innovative approaches, such as trimodality.

Alongside Miller is Dr. Dong M. Shin who serves as the director of the Clinical and Translational Cancer Prevention Program. Equally involved in the treatment and research of Mesothelioma, he has had continued success treating patients utilizing vitamin therapy. A strong proponent of early diagnosis, Shin has meticulously worked to create and improve the ability to recognize those patients who are more at risk for chronic diseases using biomarkers.

The oncology team is another superb addition to the patient care at WCI, lead by Dr. Suresh Ramalingam, the director of the Division of Medical Oncology.

An international specialist in mesothelioma, his commitment and expertise has brought superiority to the patient care at the institute as well as innovations with his groundbreaking approach to translational research. He maintains a reputable reputation as the head of the Discovery and Developmental Therapeutics Program at the institute.

The treatment of cancer and mesothelioma is one that requires the mastery of numerous medical disciplines. For this reason, Winship Cancer Institute contains multiple research programs including Cancer Prevention and Control and Discovery and Developmental Therapeutics. These programs work tirelessly to bring developments and discoveries in their respective areas allowing for further discussion amongst various medical specialists.

Winship is one of the leading medical institutions that strongly encourages clinical trials in translational research and improved clinical treatments. This often entails the use of new drugs to study their effectiveness and safety in patients suffering from chronic disease. Emory’s Woodruff Health Sciences Center makes for the perfect laboratory environment for the advancement of these trials, with over 20 currently being executed.

These clinical trials are the lifeblood of improving patients’ treatment options and are the primary reason for the institution’s success in improving the lifespan and quality of patients.

Article Sources


Page Contributors